Featured Research

from universities, journals, and other organizations

Encouraging Results Reported For New Breast Cancer Therapy

Date:
February 9, 2000
Source:
Mayo Clinic
Summary:
Mayo Clinic researchers report "encouraging" results with a new treatment for women with metastatic breast cancer. The researchers tested a combination of two drugs -- paclitaxel and carboplatin -- on 53 women. They reported a response rate (that is, evidence of tumor shrinkage) in 62 percent of the women and a projected one-year survival rate of 72 percent -- after follow-up ranging from 12 to 21 months.

ROCHESTER, MINN. -- Mayo Clinic researchers report "encouraging" results with a new treatment for women with metastatic breast cancer. The researchers tested a combination of two drugs -- paclitaxel and carboplatin -- on 53 women. They reported a response rate (that is, evidence of tumor shrinkage) in 62 percent of the women and a projected one-year survival rate of 72 percent -- after follow-up ranging from 12 to 21 months.

Edith Perez, M.D., an oncologist at Mayo Clinic in Jacksonville, Fla., who led the multi-center study, said this is one of the highest response rates of any treatment for advanced breast cancer ever tested at Mayo Clinic.

She said this drug combination has been widely used in the treatment of ovarian and lung cancer but never before tried in breast cancer in the United States.

"It's too early to know the long-term success of this treatment," she says. "But these early results are encouraging enough to serve as the basis for a number of new initiatives with this drug combination, both at Mayo Clinic and elsewhere."

One of the advantages of the new treatment, according to Dr. Perez, is that it is compatible with prior treatment with anthracycline, a drug commonly given to many women in the past for recurrent breast cancer. "This new combination is an additional therapy that adds additional benefits for these women," she says. The report appeared in a recent issue of the journal Cancer.

About 185,000 women are diagnosed with breast cancer every year. About ten percent have metastatic disease at the time of diagnosis, and about 40-50 percent of the others eventually develop metastatic disease, according to Dr. Perez.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Encouraging Results Reported For New Breast Cancer Therapy." ScienceDaily. ScienceDaily, 9 February 2000. <www.sciencedaily.com/releases/2000/02/000209074955.htm>.
Mayo Clinic. (2000, February 9). Encouraging Results Reported For New Breast Cancer Therapy. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2000/02/000209074955.htm
Mayo Clinic. "Encouraging Results Reported For New Breast Cancer Therapy." ScienceDaily. www.sciencedaily.com/releases/2000/02/000209074955.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins